Health ❯ Healthcare

Oncology

Cancer Treatment Breast Cancer Lung Cancer Clinical Trials Cancer Research Patient Care Cancer Treatments Pediatric Oncology Lymphoma Prostate Cancer

Jackie Tohn Reveals Preventive Double Mastectomy After BRCA1 Test

Her disclosure aims to spur genetic testing guided by family history through a new partnership with Myriad Genetics.

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

Imfinzi With Enfortumab Vedotin Improves Survival in Phase III Bladder Cancer Trial

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

MD Anderson Maps Triple-Negative Breast Cancer at Single-Cell Resolution and Unveils 13-Gene Model to Predict Chemo Response

Ivermectin Combo Prescriptions Jump After Mel Gibson Podcast, Study Finds

FDA Clears All-Oral Decitabine/Cedazuridine Plus Venetoclax for Older AML Patients

CRISPR CD33-Deleted Stem Cell Transplant Shows Early Promise for AML and MDS

FDA Approves Bizengri for NRG1 Fusion Cholangiocarcinoma Under Accelerated Pathway

King Charles Visits Guy’s Cancer Centre, Tests Surgical Robot, Meets Patients

Slow-Cycling ER-Positive Cells Linked to Late Breast Cancer Relapse

Gilead Lifts 2026 Sales Outlook, Warns of Loss on $11.5 Billion Deal Charge

NEJM Study and FDA Access Advance Daraxonrasib for Pancreatic Cancer

Preclinical Combo Reprograms Tumor Immunity to Overcome Colorectal Cancer Resistance

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

Pfizer’s Elrexfio Posts Phase 3 PFS Win Over Standard Multiple Myeloma Regimen

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen